ARTICLE | Clinical News
Visible Genetics regulatory update
September 9, 1996 7:00 AM UTC
VGINF received two U.S. patents covering methods and test kits that permit the rapid detection of mutations in two genes associated with cancers. Patent No. 5,545,527, covers the p53 GeneKit, which al...